Berczi, A.S.; Lampé, O.; Krasznai, Z.T.; Orosz, M.; Fábián, L.; Lampé, R.
Selective Advantage of NACT in Advanced Ovarian Cancer: A Retrospective Single-Centre Analysis. Medicina 2025, 61, 1493.
https://doi.org/10.3390/medicina61081493
AMA Style
Berczi AS, Lampé O, Krasznai ZT, Orosz M, Fábián L, Lampé R.
Selective Advantage of NACT in Advanced Ovarian Cancer: A Retrospective Single-Centre Analysis. Medicina. 2025; 61(8):1493.
https://doi.org/10.3390/medicina61081493
Chicago/Turabian Style
Berczi, Adrienne Szilvia, Olivér Lampé, Zoárd Tibor Krasznai, Mónika Orosz, Lili Fábián, and Rudolf Lampé.
2025. "Selective Advantage of NACT in Advanced Ovarian Cancer: A Retrospective Single-Centre Analysis" Medicina 61, no. 8: 1493.
https://doi.org/10.3390/medicina61081493
APA Style
Berczi, A. S., Lampé, O., Krasznai, Z. T., Orosz, M., Fábián, L., & Lampé, R.
(2025). Selective Advantage of NACT in Advanced Ovarian Cancer: A Retrospective Single-Centre Analysis. Medicina, 61(8), 1493.
https://doi.org/10.3390/medicina61081493